Innovative robust basophil activation test using a novel gating strategy reliably diagnosing allergy with full automation
Authors:
Open Access
Abstract
Background: Allergy is one of the most common chronic diseases in Europe. Therefore, an increased need for specific and sensitive diagnostic tests that truly detect allergy exists. This study aimed at establishing a highly specific high‐throughput and automated basophil activation test (BAT) that proves the existence of an allergy with utmost probability.Methods: BAT from 1104 samples was analyzed; a novel gating strategy with three antibodies (FcεRIα, CD203c, CD63) was established and compared with our published protocol (12 antibodies). Based on the novel gating strategy, storage conditions, automated measurement, and analyses using R (1376 samples out of 1389) were optimized to set up a high‐throughput BAT.Results: No differences in sensitivity and specificity were found between the novel three antibody (FcεRIα, CD203c, CD63) and the 12 antibody gating strategy or between automated and manually analyzed samples (saving up to 90% of labor time). The time frame for basophil activation measurement after blood donation has been extended considerably (whole blood storage ≤7 days (RT) and 17 days (4°C) prior to BAT preparation and measurement). Respective storage conditions were optimized for samples after stimulation, staining, and preparation (≤7 days (RT) and 28 days (4°C)). These achievements were confirmed by a nationwide ring trial showing robustness and applicability of our BAT on a variety of flow cytometers.Conclusion: Our considerable optimizations overcame the hurdles that until now prevented the BAT from being used as high‐throughput allergy diagnostic test in routine laboratories and shall allow for collaborative studies between clinics and research centers.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (JA 1007/2‐1, JA 1007/2‐3)
- Deutsche Zentrum für Lungenforschung
This publication has 38 references indexed in Scilit:
- Basophil Activation Test in Allergy: Time for an Update?International Archives of Allergy and Immunology, 2012
- CCR3 as a single selection marker compared to CD123/HLADR to isolate basophils in flow cytometry: Some commentsCytometry Part A, 2010
- Robust expression of CCR3 as a single basophil selection marker in flow cytometryAllergy, 2010
- The use of IL‐3 in basophil activation tests is the real pitfallCytometry Part B: Clinical Cytometry, 2010
- CCR3 for basophil activation test: a necessary but insufficient stepClinical & Experimental Allergy, 2010
- CD203c‐based basophil activation test in allergy diagnosis: Characteristics and differences to CD63 upregulationCytometry Part B: Clinical Cytometry, 2010
- A new basophil activation test using CD63 and CCR3 in allergy to antibioticsClinical & Experimental Allergy, 2010
- Basophil activation test by flow cytometry: Present and future applications in allergologyCytometry Part B: Clinical Cytometry, 2008
- Analysis of the composition of an immunoglobulin E reactive high molecular weight protein complex of peanut extract containing Ara h 1 and Ara h 3/4Proteomics, 2005
- Monitoring human basophil activation via CD63 monoclonal antibody 435Journal of Allergy and Clinical Immunology, 1991